This inventor holds 3 USPTO granted patents and 9 published patent applications and 10 EPO patents. Top assignee: Sansure Biotech Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Zhongping Deng
Introduction
Zhongping Deng is an accomplished inventor based in Changsha, China. He is currently associated with Sansure Biotech Inc., where he focuses on advancements in molecular biology detection. Despite having no granted patents, his contributions to the field are noteworthy.
Latest Patent Applications
Zhongping Deng has been involved in several significant patent applications. One of his latest applications is titled "COMPOSITION, KIT, METHOD FOR DETECTING HIV-1 AND USE THEREOF." This application pertains to the detection of HIV-1, providing a kit that includes a composition for effective detection. The method allows for the detection of HIV-1 with a sensitivity of 22 IU/ml, utilizing a reaction system that combines two sets of primers and probes for different regions. This innovation aims to reduce false negatives, particularly for group O viruses, while minimizing costs by eliminating the need for a fully enclosed diagnostic system.
Another notable application is "COMPOSITIONS, KITS, METHODS FOR DETECTING AND IDENTIFYING PATHOGENS THAT CAUSE RESPIRATORY TRACT INFECTIONS AND USE THEREOF." This application focuses on the simultaneous detection of multiple pathogens responsible for respiratory tract infections, including Influenza A and B viruses, Rhinovirus, Respiratory adenovirus, Respiratory syncytial virus, and Mycoplasma pneumoniae. The compositions developed in this application offer a higher detection rate and improved accuracy compared to existing methods.
Conclusion
Zhongping Deng's work at Sansure Biotech Inc. highlights his commitment to advancing molecular biology detection technologies. His innovative approaches in detecting HIV-1 and respiratory pathogens demonstrate his potential impact on public health.